May 27, 2015 Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H1 2015 Press release distribution, EDGAR filing, XBRL, regulatory filings | Business Wire The global leader in press release distribution and regulatory disclosure. Public relations...

Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca This study is currently recruiting participants. (see Contacts and Locations ) Verified October 2014 by Ocular Technologies SARL Sponsor:...